Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Congress Scientific Watch

The Congress Scientific Watch provides ESMO Members with fresh comments and analysis from selected abstracts presented during major international Oncology meetings (in partnership with medwireNews).

Video interviews from AACR 2022

Filter by:

73 results

Anticancer Agents;  Gastrointestinal Cancers;  Pancreatic Cancer;  Personalised/Precision Medicine

KRYSTAL-1: Adagrasib Demonstrates Activity Against Pancreatic, GI cancers

From ASCO GI 2022:
Patients with pancreatic ductal adenocarcinoma and other non-CRC gastrointestinal tumours with a KRASG12C mutation have achieved partial responses and stable disease with adagrasib

Immunotherapy;  Lymphomas

Liso-Cel CAR T-Cell Therapy May TRANSFORM Second-Line LBCL Care

From the 63rd American Society of Hematology Annual Meeting:
Lisocabtagene maraleucel significantly improves event-free survival versus standard care for patients with relapsed or refractory large B-cell lymphoma

Immunotherapy;  Lymphomas

Axi-Cel Extends Relapsed/Refractory Large B-Cell Lymphoma EFS

From the 63rd American Society of Hematology Annual Meeting:
Second-line anti-CD19 chimeric antigen receptor T-cell therapy offers alternative to standard chemoimmunotherapy and transplantation for large B-cell lymphoma

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.